UCIR

Cancer vaccines are getting a national push. The NIH plans a public-private partnership to speed up personalized vaccines that train a patient’s own immune system to fight their cancer.
nyti.ms/4dHt9Mh

New in Nature Medicine: researchers may have found why some myeloma patients get severe gut inflammation after BCMA CAR-T.
👉 CAR-T cells can linger in the intestine and inflammation ramps up. A JAK inhibitor helped 2 patients in early findings. #CART #MultipleMyeloma

New research from Mount Sinai: patients 80+ with early-stage lung cancer can safely undergo surgery with outcomes comparable to younger patients. Age alone shouldn't determine who gets a chance at a cure. (The Lancet Regional Health – Americas) bit.ly/41aaYYY

CAR T-cell therapy is being tested in more types of childhood cancers - not just blood cancers, but also in brain tumors and solid tumors. 🎗 Learn how it works 👉 bit.ly/3ZkOHEj ️#ChildhoodCancerAwareness #Immunotherapy #CARTcells

A study shows that the genes we inherit from birth don’t just affect our risk of cancer. They can also shape how tumors interact with the immune system. It could explain why some people respond well to cancer immunotherapy while others don’t.
Read more 👉 bit.ly/4nCn1Y4